Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19)

We performed a meta-analysis to determine safety and efficacy of tocilizumab in persons with coronavirus disease-2019 (COVID-19). We searched PubMed, Web of Science and Medline using Boolean operators for studies with the terms coronavirus OR COVID-19 OR 2019-nCoV OR SARS-CoV-2 AND tocilizumab. Revi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chong-xiang, Hu, Fang, Wei, Jin, Yuan, Le-tao, Wen, Tian-meng, Gale, Robert Peter, Liang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127467/
https://www.ncbi.nlm.nih.gov/pubmed/34002026
http://dx.doi.org/10.1038/s41375-021-01264-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127467/
https://www.ncbi.nlm.nih.gov/pubmed/34002026
http://dx.doi.org/10.1038/s41375-021-01264-8

Ejemplares similares